These limitations include the need for the verification of results in additional models of atherosclerosis including the transgenic models of atherosclerosis such as ldlr-, aopE-, or pcsk9-deficient mice as well as in rhesus monkeys. This evidence concerns the gene PCSK9 and atherosclerosis.